Related Experiment Video
Updated: Feb 1, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Prognostic role of microRNA-155 expression in gliomas: A meta-analysis
Yan Zhou1, Xuan Wang1, Zhen Liu1
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Abstract:
Recent studies have reported that microRNA-155 (miR-155) is linked to the clinical outcomes of many tumors. However, its role in prognosis of gliomas remains unclear. This meta-analysis aims to evaluate the prognostic value of miR-155 in the survival of patients with gliomas. Hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS) were pooled with random effects or fixed effects models on the basis of heterogeneity. Subgroup analysis and sensitivity analysis were performed to elucidate the possible confounding factors and investigate the source of heterogeneity. In addition, we assessed publication bias using the Begg's funnel plots, Egger's test, and Begg's test. Only non-laboratory studies were considered for our analysis. 9 studies from 6 articles containing 1259 glioma patients were included. The pooled HR of elevated miR-155 for OS in patients with gliomas was 1.40 (95%CI [1.19-1.63], P < 0.001) (I-squared = 52.4%, P = 0.032) suggesting that miR-155 might be a promising biomarker for the prognosis of gliomas in future clinical applications.
Insights
MicroRNA-155 (miR-155) shows potential as a prognostic biomarker in glioma patients. Elevated miR-155 levels are associated with poorer overall survival, indicating its clinical relevance.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Research
Background:
- MicroRNA-155 (miR-155) is implicated in the clinical outcomes of various cancers.
- The prognostic significance of miR-155 in glioma, a primary brain tumor, requires further clarification.
Purpose of the Study:
- To conduct a meta-analysis evaluating the prognostic value of miR-155 in glioma patient survival.
- To determine if miR-155 can serve as a reliable biomarker for glioma prognosis.
Main Methods:
- Meta-analysis of non-laboratory studies focusing on miR-155 and glioma overall survival (OS).
- Pooled hazard ratios (HRs) using random or fixed effects models, assessed heterogeneity, performed subgroup and sensitivity analyses.
- Publication bias evaluated using Begg's funnel plots and Egger's test.
Main Results:
- Included 9 studies with 1259 glioma patients.
- Elevated miR-155 was associated with significantly poorer OS in glioma patients (HR = 1.40, 95% CI [1.19-1.63], P < 0.001).
- Heterogeneity was observed (I-squared = 52.4%, P = 0.032), necessitating further investigation.
Conclusions:
- miR-155 may function as a promising prognostic biomarker for glioma.
- Elevated miR-155 levels correlate with adverse survival outcomes in glioma patients.
- Further clinical validation is warranted to establish miR-155 in glioma prognosis.
Related Concept Videos
MicroRNAs
MicroRNAs
Directing Effect of Substituents: meta-Directing Groups
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture

